Filter By Industry
Filter By Tag

Newsroom

Datastring Consulting Press releases

1 - 10 of 35 Press Releases

Sep 08, 2025
Industry revenue for Levoketoconazole is estimated to rise to $461.6 million by 2035 from $194.0 million of 2024. The revenue growth of market players is expected to average at 8.2% annually for the period 2024 to 2035.

Sep 01, 2025
Industry revenue for Monomethyl Fumarate is estimated to rise to $618.1 million by 2035 from $309.2 million of 2024. The revenue growth of market players is expected to average at 6.5% annually for the period 2024 to 2035.

Aug 26, 2025
Industry revenue for Molindone Hydrochloride is estimated to rise to $413.0 million by 2035 from $226.8 million of 2024. The revenue growth of market players is expected to average at 5.6% annually for the period 2024 to 2035.

Aug 19, 2025
Industry revenue for Mercury Arc Rectifiers is estimated to rise to $2.5 billion by 2035 from $1.5 billion of 2024. The revenue growth of market players is expected to average at 4.9% annually for the period 2024 to 2035.

Aug 19, 2025
Industry revenue for Trimaran Vessels is estimated to rise to $14.4 billion by 2035 from $5.9 billion of 2024. The revenue growth of market players is expected to average at 8.5% annually for the period 2024 to 2035.

Aug 12, 2025
Industry revenue for Vistogard is estimated to rise to $3.2 billion by 2035 from $1.0 billion of 2024. The revenue growth of market players is expected to average at 11.0% annually for the period 2024 to 2035.

Aug 12, 2025
Industry revenue for Triamterene Capsules is estimated to rise to $1437.5 million by 2035 from $797.7 million of 2024. The revenue growth of market players is expected to average at 5.5% annually for the period 2024 to 2035.

Aug 05, 2025
Industry revenue for Pet Wearable is estimated to rise to $10.9 billion by 2035 from $3.4 billion of 2024. The revenue growth of market players is expected to average at 11.2% annually for the period 2024 to 2035.

Aug 05, 2025
Industry revenue for Height Adjustable Standing Desks is estimated to rise to $7.8 billion by 2035 from $2.9 billion of 2024. The revenue growth of market players is expected to average at 9.4% annually for the period 2024 to 2035.

Jul 29, 2025
Industry revenue for 3d Bioprinting is estimated to rise to $9.2 billion by 2035 from $1.7 billion of 2024. The revenue growth of market players is expected to average at 16.4% annually for the period 2024 to 2035.


Page: 1 2 3 4 Next
Datastring Consulting RSS Feed